Evidence map›Paper›PMID 24377879›Full record

ArticleEmerging infectious diseases2014

Drug-resistant tuberculosis in high-risk groups, Zimbabwe.

John Z Metcalfe, Salome Makumbirofa, Beauty Makamure, Charles Sandy, Wilbert Bara, Stanley Mungofa, Philip C Hopewell, Peter Mason

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Emerging infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 3 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 3 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Prevalence of drug-resistant tuberculosis in Zimbabwe: A health facility-based cross-sectional survey.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2019
    Article
  9. Article
  10. Chronic lung disease in adult recurrent tuberculosis survivors in Zimbabwe: a cohort study.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2019
    Article
  11. Article
  12. Article
  13. Article
  14. Xpert(®) MTB/RIF detection of rifampin resistance and time to treatment initiation in Harare, Zimbabwe.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2016
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

John Z Metcalfe
Salome Makumbirofa
Beauty Makamure
Charles Sandy
Wilbert Bara
Stanley Mungofa
Philip C Hopewell
Peter Mason
National Blood Service Zimbabwe · ZWUniversity of Zimbabwe · ZWBiomedical Research and Training Institute · ZW

Funding

Improving Early Identification of Drug Resistant Tuberculosis in HIV Prevalent SeK23AI094251 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI METCALFE, JOHN ZAPATA · 2011 to 2015
$625k
NIAID NIH HHS K23 AI094251PHS HHS U52/CCU900454
6 · The paper itself

Abstract

To estimate prevalence of multidrug-resistant tuberculosis (MDR TB) in Harare, Zimbabwe, in 2012, we performed microbiologic testing on acid-fast bacilli smear-positive sputum samples from patients previously treated for TB. Twenty (24%) of 84 specimens were consistent with MDR TB. A national drug-resistance survey is needed to determine MDR TB prevalence in Zimbabwe.

Indexed as

Drug Resistance, Multiple, BacterialHumansMicrobial Sensitivity TestsMycobacterium tuberculosisPrevalenceProspective StudiesTuberculosis, Multidrug-ResistantZimbabweantimicrobial resistancebacteriadrug-resistant tuberculosisHIV/TBMDR TBmycobacteriaMycobacterium tuberculosisretreatment tuberculosistuberculosisZimbabwe

Identifiers

PMID24377879
PMCPMC3884722
OpenAlexW2041724204

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.